Amin Saiff Johari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amin Saiff Johari has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Muhamad Hazri Othman
Advanced Materials Research Centre (AMREC), SIRIM Industrial Research, SIRIM Berhad, Kulim, Kedah, 09000, Malaysia
2 shared publications- Azman Seeni
Universiti Sains Malaysia
1 shared publication - Fatimah Salim
Atta-Ur-Rahman Institute for Natural Product Discovery (AuRIns), Universiti Teknologi MARA (UiTM), Selangor Branch, Puncak Alam Campus, Selangor, 42300, Malaysia
1 shared publication - Mohd Shahrul Nizam Salleh
Advanced Materials Research Centre (AMREC), SIRIM Industrial Research, SIRIM Berhad, 09000, Kulim, Kedah, Malaysia
1 shared publication - Nur Ayunie Zulkepli
Atta-Ur-Rahman Institute for Natural Product Discovery (AuRIns), Universiti Teknologi MARA (UiTM), Selangor Branch, Puncak Alam Campus, Selangor, 42300, Malaysia / Centre for Medical Laboratory Technology Studies, Faculty of Health Sciences, Universiti Teknologi MARA (UiTM) Selangor Branch, Puncak Alam Campus, Selangor, 42300, Malaysia
1 shared publication Nur Shahida Kader Bashah
Advanced Materials Research Centre (AMREC), SIRIM Industrial Research, SIRIM Berhad, Kulim, Kedah, 09000, Malaysia
1 shared publication
Latest Publications
- Open Access
- 21 July 2026
- Published by Metallurgy and Materials Science Research Institute, Chulalongkorn University in Journal of Metals, Materials and Minerals
- Vol. 36 (4) , e2657
Physicochemical characterization and in vitro biocompatibility assessment of hydrothermally synthesized hydroxyapatite from oyster shells
Naturally produced Hydroxyapatite (HAP) yields beneficial attributes with regards to its biological functions including cell compatibility, proliferation and osteoinduction. This study synthesized HAP from oyster shells as a calcium source with multiple hydrothermal reaction times including 1 h, 6 h and 24 h at 150℃. A wet precipitated control sample was produced at room temperature. Characterization using FTIR, XRD, SEM-EDX and BET were conducted, followed by a degradation analysis. Bio-compatibility study of Oys-HAP was performed against Saos-2 osteoblast-like cells. The results showed nano scaled elongated and oval-shaped Oys-HAP particles with high crystallinity, beta-type carbonated, non-stoichiometric Ca/P ratio with a maximum surface area of 41.39 m2·g‒1. Furthermore, Oys-HAP samples were non-toxic and significantly enhanced Saos-2 cell proliferation by 65.6% compared to the negative control. These findings demonstrate the potential of oyster shell-derived Oys-HAP as a sustainable and effective biomaterial for biomedical applications.
- 21 July 2026
- Published by Metallurgy and Materials Science Research Institute, Chulalongkorn University in Journal of Metals, Materials and Minerals
- Vol. 36 (4) , e2657
Open AccessPhysicochemical characterization and in vitro biocompatibility assessment of hydrothermally synthesized hydroxyapatite from oyster shells
Naturally produced Hydroxyapatite (HAP) yields beneficial attributes with regards to its biological functions including cell compatibility, proliferation and osteoinduction. This study synthesized HAP from oyster shells as a calcium source with multiple hydrothermal reaction times including 1 h, 6 h and 24 h at 150℃. A wet precipitated control sample was produced at room temperature. Characterization using FTIR, XRD, SEM-EDX and BET were conducted, followed by a degradation analysis. Bio-compatibility study of Oys-HAP was performed against Saos-2 osteoblast-like cells. The results showed nano scaled elongated and oval-shaped Oys-HAP particles with high crystallinity, beta-type carbonated, non-stoichiometric Ca/P ratio with a maximum surface area of 41.39 m2·g‒1. Furthermore, Oys-HAP samples were non-toxic and significantly enhanced Saos-2 cell proliferation by 65.6% compared to the negative control. These findings demonstrate the potential of oyster shell-derived Oys-HAP as a sustainable and effective biomaterial for biomedical applications.
- Open Access
- 30 December 2025
- Published by Indonesian Young Scientist Group in Pharmacy Reports
- Vol. 5 (3) , 163
Pyrrolidone-doped cellulose acetate nanofibers: a preliminary field evaluation in a mobile air filtration unit for clinical use
Airborne microbial contamination remains a persistent threat to patient safety in clinical settings, and conventional bioaerosol control strategies, particularly HEPA-based filtration, are limited by their inability to inactivate trapped microorganisms, which can continue to proliferate within the filter and recirculate into the air. This study presents a preliminary field evaluation of pyrrolidone-doped cellulose acetate (CA) nanofibers integrated into a mobile air filtration unit, aimed at reducing airborne microbial burden in a real clinical environment. The filtration unit was deployed for four weeks in an observation ward at a general hospital, and antibacterial efficacy was assessed using in situ filter sampling and active air sampling, with isolate identification performed via 16S rRNA gene sequencing. The pyrrolidone-doped CA filter achieved a significant reduction in bacterial colony counts of 51.70% at week 1 (p < 0.05), though the reduction observed at week 4 (21.68%) was not statistically significant. Active air sampling showed corresponding, non-significant reductions in airborne bacterial load of 9.52% at week 1 and 5% at week 4. Four bacterial genera were isolated from the ward air, namely Bacillus, Staphylococcus, Priestia, and Acinetobacter, including Acinetobacter baumannii, a WHO priority pathogen associated with multidrug resistance. These findings provide preliminary evidence that pyrrolidone-doped CA nanofiber filtration can meaningfully reduce short-term airborne bacterial burden in a clinical setting, while also highlighting a decline in efficacy over prolonged use that warrants further investigation into filter longevity and replacement intervals. Larger-scale, controlled studies are needed to validate this strategy as a viable adjunct for improving indoor air quality and reducing hospital-acquired infection risk.
- 30 December 2025
- Published by Indonesian Young Scientist Group in Pharmacy Reports
- Vol. 5 (3) , 163
Open AccessPyrrolidone-doped cellulose acetate nanofibers: a preliminary field evaluation in a mobile air filtration unit for clinical use
Airborne microbial contamination remains a persistent threat to patient safety in clinical settings, and conventional bioaerosol control strategies, particularly HEPA-based filtration, are limited by their inability to inactivate trapped microorganisms, which can continue to proliferate within the filter and recirculate into the air. This study presents a preliminary field evaluation of pyrrolidone-doped cellulose acetate (CA) nanofibers integrated into a mobile air filtration unit, aimed at reducing airborne microbial burden in a real clinical environment. The filtration unit was deployed for four weeks in an observation ward at a general hospital, and antibacterial efficacy was assessed using in situ filter sampling and active air sampling, with isolate identification performed via 16S rRNA gene sequencing. The pyrrolidone-doped CA filter achieved a significant reduction in bacterial colony counts of 51.70% at week 1 (p < 0.05), though the reduction observed at week 4 (21.68%) was not statistically significant. Active air sampling showed corresponding, non-significant reductions in airborne bacterial load of 9.52% at week 1 and 5% at week 4. Four bacterial genera were isolated from the ward air, namely Bacillus, Staphylococcus, Priestia, and Acinetobacter, including Acinetobacter baumannii, a WHO priority pathogen associated with multidrug resistance. These findings provide preliminary evidence that pyrrolidone-doped CA nanofiber filtration can meaningfully reduce short-term airborne bacterial burden in a clinical setting, while also highlighting a decline in efficacy over prolonged use that warrants further investigation into filter longevity and replacement intervals. Larger-scale, controlled studies are needed to validate this strategy as a viable adjunct for improving indoor air quality and reducing hospital-acquired infection risk.